EMA for Predicting Treatment Outcomes in Patients With SUD
TEMPTATION
Neuropsychological Assessment in Real Time of the Implicit Cognition in the Prediction of Relapse of Patients With Substance Use Disorder
1 other identifier
observational
130
1 country
1
Brief Summary
This longitudinal repeated measures study will evaluate participants at the beginning of treatment through an assessment of psychological measures and craving. They will be trained to use a mobile platform, which will be available for 12 days. The assessment will be conducted via Ecological Momentary Assessment (EMA), with scheduled daily access and during situations of consumption risk. Each access will include questions on substance use, depression, anxiety, triggering situations, attitude towards drugs, and a cognitive bias test. The platform will alternate between two tests (Drug Stroop Task and WAT-DUD). Participants will follow a treatment program supervised by professionals. The study aims to recruit 130 participants (65 for alcohol, 65 for cocaine) from the Provincial Service for Drug Dependence and Addictions in Huelva (SPDA). Participants, selected via stratified random sampling, must reside in Huelva, sign informed consent, have a compatible mobile device, and be over 18. Anonymity will be ensured through alphanumeric codes. Upon treatment admission, selected patients will be informed of their participation in the study. Interviews, conducted by psychologists, will outline the study objectives and duration. Patients agreeing to participate will sign informed consent and receive an identification code. Baseline assessment data will be integrated into a database for subsequent statistical analysis. The assessment encompasses the collection of four blocks of information: Block 1. Patients medical history initiated during treatment admission. Block 2. Neuropsychological battery developed by the research team for the baseline evaluation. Block 3. Neuropsychological battery developed by the research team for the web platform measured through Ecological Momentary Assessment (EMA). Block 4. Follow-up information at three and six months provided by SPDA professionals through the patients medical history. To ensure compliance with participant follow-up, a mixed monitoring protocol has been developed, which includes phone calls and WhatsApp messages. This protocol is designed according to social exchange theory so that participants perceive the benefits of their participation as outweighing the costs. The statistical analysis involves identifying outliers and trimming distributions. Data will be averaged per test per person, considering different conditions. Repeated measures ANOVA will analyze factors such as gender and substance type to address study objectives, examining interactions and conducting planned contrasts for specific comparisons.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 21, 2023
CompletedFirst Submitted
Initial submission to the registry
May 24, 2024
CompletedFirst Posted
Study publicly available on registry
June 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedJune 24, 2024
June 1, 2024
2 years
May 24, 2024
June 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Differences between daily access scores and temptation access scores
We may find statistically significant differences between the scores obtained during episodes of temptation to consume or purchase substances and those obtained from daily measures, with higher scores during temptation episodes. These differences will be observed in both groups, among both men and women.
Through study completion, an average of 2 years
Relationship between number of episodes of temptations and scores in the tests
It may be that during the monitoring, those participants who experience a higher number of episodes of temptation will have elevated levels in the scheduled measures. Those participants who have higher scores during episodes of temptation will have a greater number of episodes of consumption. These relationships will be observed in both groups, among both men and women.
Through study completion, an average of 2 years
Differences based on the type of substance
There may be statistically significant differences in the test scores based on the type of substance.
Through study completion, an average of 2 years
Relationship between the studied variables and variables associated with gender.
We may find differences in test scores based on gender-related variables.
Through study completion, an average of 2 years
Eligibility Criteria
Individuals receiving treatment for Substance Use Disorder (SUD) at the Provincial Service for Drug Dependence and Addictions (SPDA) in the province of Huelva, Spain.
You may qualify if:
- Patients initiating treatment for addiction to cocaine or alcohol as the primary substance.
- Patients with a diagnosis of Substance Use Disorder of mild, moderate, or severe severity, according to the 5th Edition of the DSM (Diagnostic and Statistical Manual of Mental Disorders).
- Maintaining residency in the province of Huelva during the study\'s follow-up period.
- Willingness to participate in the study by providing informed consent.
- Possessing a mobile device that meets the necessary technical requirements for the installation and operation of the application.
You may not qualify if:
- Patients with severe, unstable mental disorders, as assessed by the clinical team at the treatment centers.
- Patients with physical or mental disorders that hinder the execution of the tests and assessments included in the study.
- Patients under the age of 18.
- Patients with opioid consumption.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Huelvalead
- Ministerio de Economía y Competitividad, Spaincollaborator
- State Research Agency, Spaincollaborator
Study Sites (1)
University of Huelva
Huelva, 21007, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Enrique Moraleda-Barreno, PhD
University of Huelva
- PRINCIPAL INVESTIGATOR
José A. Lorca-Marín, PhD
University of Huelva
- PRINCIPAL INVESTIGATOR
Ana Segura-Barriga, Graduate
University of Huelva
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 24, 2024
First Posted
June 24, 2024
Study Start
July 21, 2023
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
June 24, 2024
Record last verified: 2024-06